Synthesis and evaluation of salvinorin A analogues as kappa-opioid receptor ligands for the treatment of mood disorders.

被引：0
|
作者：
Beguin, C
Richards, MR
Liu-Chen, LY
Lee, DYW
Carlezon, WA
Cohen, BM
机构：
[1] Harvard Univ, Sch Med, McLean Hosp, Mol Pharmacol Lab, Belmont, MA 02478 USA
[2] Temple Univ, Sch Med, Dept Pharmacol, Philadelphia, PA 19122 USA
[3] McLean Hosp, HMS, Bioorgan & Nat Prod Lab, Belmont, MA 02178 USA
[4] McLean Hosp, HMS, Behav Genet Lab, Belmont, MA 02178 USA
来源：
ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY | 2005年 / 229卷
关键词：
D O I：
暂无
中图分类号：
O6 [化学];
学科分类号：
0703 ;
摘要：
069-MEDI
引用
收藏
页码：U118 / U118
页数：1
相关论文
共 50 条
  • [41] Importance of homology modeling template selection: CXCR4-based model of the kappa-opioid receptor with the novel hallucinogen salvinorin A
    Mosier, Philip D.
    Koparde, Vishal N.
    Westkaemper, Richard B.
    Roth, Bryan L.
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2011, 242
  • [42] Topical treatment with a novel kappa-opioid receptor agonist ameliorates atopic dermatitis
    Schneeweiss, M.
    Luediger, A.
    Chartolani, N.
    Soeberdt, M.
    Knie, U.
    Luger, T. A.
    Abels, C.
    Loser, K.
    EXPERIMENTAL DERMATOLOGY, 2018, 27 (03) : E47 - E47
  • [43] PREPARATION AND EVALUATION OF SOME HYDROPHILIC PHENYLACETYLPIPERAZINES AS PERIPHERALLY SELECTIVE KAPPA-OPIOID RECEPTOR AGONISTS
    BIRCH, PJ
    HAYES, AG
    JOHNSON, MR
    LEA, TA
    MURRAY, PJ
    ROGERS, H
    SCOPES, DIC
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 1992, 2 (10) : 1275 - 1278
  • [44] Post-receptor signaling pathways in the pathophysiology and treatment of mood disorders.
    Manji H.K.
    Chen G.
    Current Psychiatry Reports, 2000, 2 (6) : 479 - 489
  • [45] Ligand-based approach for the identification of novel ligands:: Application to Salvinorin A, a selective kappa opioid receptor (KOP) agonist
    Singh, Nidhi
    Cheve, Gwenael
    Narayanan, Sanju
    McCurdy, Christopher R.
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2006, 231
  • [46] Rationale and synthesis of novel dual δ/μ opioid receptor agonists for motility disorders.
    Breslin, HJ
    Miskowski, TA
    Coutinho, SV
    Palmer, JM
    Zhang, SP
    Kimball, ES
    Colburn, RW
    Stone, DJ
    Andrade-Gordon, P
    Hornby, PJ
    He, W
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2003, 225 : U210 - U211
  • [47] Dynorphin/kappa-opioid receptor control of dopamine dynamics: Implications for negative affective states and psychiatric disorders
    Tejeda, Hugo A.
    Bonci, Antonello
    BRAIN RESEARCH, 2019, 1713 : 91 - 101
  • [48] SYNTHESIS AND ABSOLUTE-CONFIGURATION OF OPTICALLY PURE ENANTIOMERS OF A KAPPA-OPIOID RECEPTOR SELECTIVE AGONIST
    DECOSTA, B
    GEORGE, C
    ROTHMAN, RB
    JACOBSON, AE
    RICE, KC
    FEBS LETTERS, 1987, 223 (02) : 335 - 339
  • [49] Evaluation of the abuse potential of difelikefalin, a selective kappa-opioid receptor agonist, in recreational polydrug users
    Shram, Megan J.
    Spencer, Robert H.
    Qian, Jenny
    Munera, Catherine L.
    Lewis, Michael E.
    Henningfield, Jack E.
    Webster, Lynn
    Menzaghi, Frederique
    CTS-CLINICAL AND TRANSLATIONAL SCIENCE, 2022, 15 (02): : 535 - 547
  • [50] The effects of kappa-opioid receptor ligands on prepulse inhibition and CRF-induced prepulse inhibition deficits in the rat
    Hugo A. Tejeda
    Vladimir I. Chefer
    Agustin Zapata
    Toni S. Shippenberg
    Psychopharmacology, 2010, 210 : 231 - 240
12345